Nath Bio-Genes (India) Ltd (BOM:537291)
₹ 183.75 1.6 (0.88%) Market Cap: 3.49 Bil Enterprise Value: 2.83 Bil PE Ratio: 8.92 PB Ratio: 0.55 GF Score: 68/100

Q2 2024 Nath Bio-Genes (I) Ltd Earnings Call Transcript

Oct 17, 2023 / 10:30AM GMT
Release Date Price: ₹202.1 (-7.61%)
Operator

Ladies and gentlemen, good day and welcome to H1 FY24 earnings call from Nath Bio-Genes Ltd. hosted by Go India Advisors. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Deepika Sharma from Go India Advisors. Thank you and over to you, ma'am.

Deepika Sharma;Satish Kagliwal<
Go India Advisors - Senior Manager - Corporate Access

Thank you, Enzo. Good afternoon, everyone, and welcome to the H1 FY24 earnings call of Nath Bio-Genes Ltd. We have on the call Mr. Satish Kagliwal, Managing Director; Mr. Devinder Khurana, Chief Financial Officer; Mr. Harish Pandey, Business Lead; Dr. Venkatesh Kulkarni, Research Lead.

I must remind you that the discussion on today's call may include certain forward-looking statements and must be therefore viewed in conjunction with the risk that company faces.

May I now request the management to take us through the financials and the business outlook subsequent to which we will open the floor for Q&A. Thank you and over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot